Is the carcinoembryonic antigen test a valid predictor of response to medical therapy in disseminated breast cancer?
Tumori
; 72(5): 515-8, 1986 Oct 31.
Article
in En
| MEDLINE
| ID: mdl-3798573
ABSTRACT
In 30 of 63 patients with disseminated breast cancer, CEA became positive before medical therapy. Treatment response was obtained in 63.3% of CEA-positive patients compared to 15.2% of CEA-negative patients. The CEA-positive patients also had a longer relapse-free survival, a longer survival from diagnosis of metastases, and a longer overall survival from primary surgery than CEA-negative patients. CEA production appears to be an important and favorable prognostic factor in disseminated breast cancer and determinant of treatment response.
Search on Google
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Carcinoembryonic Antigen
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
1986
Type:
Article